rivaroxaban

Spain

Drugs containing this active substance

  • RIVAROXABAN VIVANTA 20 MG FILM-COATED TABLETS EFG

    It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Vivanta Generics S.R.O.

  • It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Glenmark Pharmaceuticals S.R.O.

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Glenmark Pharmaceuticals S.R.O.

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Glenmark Pharmaceuticals S.R.O.

  • It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.

    Form: capsules, hard

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Adamed Laboratorios S.L.U.

  • It is used in adults to prevent the formation of blood clots in the brain or other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing.

    Form: capsules, hard

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Adamed Laboratorios S.L.U.

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring.

    Form: capsules, hard

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Adamed Laboratorios S.L.U.

  • It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you suffer from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if suffering from non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.

  • It is used in full-term newborns, infants, children, and adolescents under 18 years of age to treat blood clots and prevent them from reappearing in the veins or pulmonary blood vessels, following an initial treatment of at least 5 days with injectable medications.

    Form: suspension, oral for preparation from granules

    Active substance Dosage
    rivaroxaban 51,7 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in veins after hip or knee replacement surgery. It is also used to treat blood clots in the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), helping to prevent their recurrence.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery, and to treat blood clots in the leg veins (deep vein thrombosis) or in the lungs (pulmonary embolism), also helping to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 10 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from recurring.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels if you have non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring. In children and adolescents weighing 30 kg or more, it is used to treat and prevent these clots after initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 15 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used to reduce the risk of suffering a new myocardial infarction or death from heart or blood vessel diseases in adults with acute coronary syndrome. It also helps to reduce the risk of clot formation in people with coronary or peripheral artery disease.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 2,5 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), as well as to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) or in other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent them from reappearing. In children and adolescents weighing 30 kg or more, it is used to treat and prevent the recurrence of these clots following initial treatment with injectable medications.

    Form: tablets, film-coated

    Active substance Dosage
    rivaroxaban 20 mg

    ATC: B01A B01AF B01AF01

    Manufacturer: Bayer Ag